Role of frenular web preservation on ejaculation latency time

Premature ejaculation [PE] is one of prevalent male sexual dysfunctions worldwide. Despite many psychiatric backgrounds, yet there are speculations about organic etiologies considering both anatomic and physiologic points of view. This survey assesses effect of frenular web preservation on premature ejaculation. One thousand and forty otherwise healthy men being visited for urolithiasis [asymptomatic patients] were asked for PE according to the International Society of Sexual Medicine definition criteria as intravaginal ejaculation latency time [IELT] less than a minute according to stop watch checked by patients' partner and were examined for presence of frenular web. Frenular web defined as a residual of frenulum after a circumcision. Overall prevalence of PE was 18.2% [n=102]. We found the presence of frenulum at physical examination in 255 out of 560 [45.5%]. Prevalence of PE was 20.7% [n=53] and 16% [n=49] in patients with frenular web preserved and without it, respectively. PE was higher among the men with frenulum preserved; but no statistically significant differences were seen [P=0.70]. We did not find any relationship between frenular web and PE, and concerns about this, during circumcision, may not be justified. PE is a not only a problem of local anatomical condition but many psychological and neurological factors could interact with it

75-year old man complaining of flank pain and obstructive urinary symptoms: a case report

Benign renal cystic adenoma with out malignant features is a very rare entity. A 75 year old male with obstructive Lower tract symptoms and vague flank pain was admitted and planned for nephrectomy of non functional kidney-due to long term nephrolithiasis-intra operative finding was a cystic hydronephrotic kidney filled by thick mucous secretions which turned out to be a cyst adenoma of kidney with no malignant features

Intravesical Bacillus Calmette-Guerin for treatment of refractory interstitial cystitis

The aim of this study was to examine the efficacy and safety of intravesical Bacillus Calmette-Guerin [BCG] in the treatment of refractory interstitial cystitis [IC]. Thirteen patients with refractory IC were enrolled in the study. They were scheduled to receive 6 weekly courses of treatment with intravesical BCG. Variables including the frequency, nocturia, urgency, pelvic pain, dyspareunia, dysuria, IC symptom index, IC problem index, and average voided volume were assessed every 6 months after the BCG therapy. Thirteen patients received the complete course of intravesical BCG therapy. Twenty-four months after the treatment a mean improvement of 51.9% was seen in frequency [P = .001], 43.2% in nocturia [P = .002], 28.7% in urgency [P = .004], 43.1% in pelvic pain [P = .001], 58.3% in dyspareunia [P = .003], 6.5% in dysuria [P = .16], 57.7% in the O'Leary-Sant 1C symptom index [P = .001], and 61.8% in the O'Leary-Sant 1C problem index [P = .001] scores. A significant improvement was seen in the mean average voided volume at the 24th follow-up month [89.5%; P = .001]. Intravesical BCG is a relatively effective treatment in patients with refractory 1C. Its efficacy seems to be modest and lasts for at least 24 months in majority of the patients. It is also safe and well tolerated